Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 1, 2014, Pages 193-200

  Fang, Yong ^a   Chen, Wei ^a   Liang, Xiao ^a   Li, Da ^a   Lou, Haizhou ^a   Chen, Renbiao ^a   Wang, Kaifeng ^a   Pan, Hongming ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Hepatectomy; Prognosis; Radiofrequency ablation; Small hepatocellular carcinoma

Indexed keywords

ALBUMIN; BILIRUBIN; IOHEXOL;

ADULT; ARTICLE; ATELECTASIS; BONE METASTASIS; BURN; CANCER REGRESSION; CHEMOEMBOLIZATION; CHEST INFECTION; CLINICAL EFFECTIVENESS; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FEVER; FOLLOW UP; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OVERALL SURVIVAL; PLEURA EFFUSION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; SEPSIS; SURVIVAL RATE; WOUND INFECTION;

HEPATECTOMY; PROGNOSIS; RADIOFREQUENCY ABLATION; SMALL HEPATOCELLULAR CARCINOMA;

ADULT; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84897596547     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12441     Document Type: Article

References (47)

1. Shi M, Qian S, Chen WW etal. Hepatitis B virus (HBV)antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinomapatients significantly enhance specific T cell responses in vitro. Clin. Exp. Immunol. 2007; 147: 277-286.
2. Ou DP, Tao YM, Tang FQ, Yang LY. The hepatitis B virus X protein promotes hepatocellularcarcinoma metastasis by upregulation of matrix metalloproteinases. Int. J. Cancer 2007; 120: 1208-1214.
3. Chen M, Therneau T, Orsini LS, Qiao YL. Design and rationale of the HCC BRIDGE study inChina: a longitudinal, multicenter cohort trial in hepatocellular carcinoma. BMC Gastroenterol. 2011; 11: 53-59.
4. Bolondi L, Sofia S, Siringo S. Surveillance programme of cirrhotic patients for early diagnosisand treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001; 48: 251-259.
5. Livraghi T, Giorgio A, Marin G. Hepatocellular carcinoma and cirrhosis in 746 patients: long-termresults of percutaneous ethanol injection. Radiology 1995; 197: 101-108.
6. Mahnken AH, Bruners P, Gunther RW. Local ablative therapies in HCC: percutaneous ethanolinjection and radiofrequency ablation. Dig. Dis. 2009; 27: 148-156.
7. Caselitz M, Gebel M, Wagner S etal. Treatment ofmultilocular hepatocellular carcinoma (HCC) of 4.5cm and 3.5cm diameter using percutaneousethanol injection in a patient with advanced liver cirrhosis. Z. Gastroenterol. 1999; 37: 1175-1178.
8. Seki T, Wakabayashi M, Nakagawa T. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999; 85: 1694-1702.
9. Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST. Analysis of recurrence pattern and itsinfluence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J. Gastrointest. Surg. 2008; 12: 183-191.
10. Liapi E, Geschwind JF. Medium-sized HCC: achieving effective local tumor control withcombined chemoebolization and radiofrequency ablation. Ann. Surg. Oncol. 2011; 18: 1527-1528.
11. Nakano H, Kikuchi K, Seta S, Katayama M, Yamamura T, Otsubo T. Preservation of segment 4inferior by distal middle hepatic vein reconstruction combined with extended right hepatectomy afterportal vein embolization in a patient with a huge initially unresectable HCC. Hepatogastroenterology 2007; 54: 1563-1566.
12. Nanashima A, Abo T, Hamasaki KL. Perioperative non-tumorous factors associated with survivalin HCC patients who underwent hepatectomy. Anticancer Res. 2011; 31: 4545-4551.
13. Montorsi M, Santambrogio R, Bianchi P. Survival and recurrences after hepatic resection orradiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J. Gastrointest. Surg. 2005; 9: 62-67.
14. Andreou A, Vauthey JN, Cherqui D. Improved long-term survival after major resection forhepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J. Gastrointest. Surg. 2013; 17: 66-77.
15. Toyoda H, Kumada T, Tada T. Prognostic significance of a combination of pre- and post-treatmenttumor markers for hepatocellular carcinoma curatively treated with hepatectomy. J. Hepatol. 2012; 57: 1251-1257.
16. Belli G, Fantini C, D'Agostino A, Belli A, Russolillo N. Laparoscopic liver resections forhepatocellular carcinoma (HCC) in cirrhotic patients. HPB (Oxford) 2004; 6: 236-246.
17. Kamiyama T, Nakanishi K, Yokoo H etal. Analysis of therisk factors for early death due to disease recurrence or progression within 1 year after hepatectomy inpatients with hepatocellular carcinoma. World J. Surg. Oncol. 2012; 10: 107-113.
18. Sheiman RG, Mullan C, Ahmed M. In vivo determination of a modified heat capacity of smallhepatocellular carcinomas prior to radiofrequency ablation: correlation with adjacent vasculature andtumour recurrence. Int. J. Hyperthermia 2012; 28: 122-131.
19. Khan MR, Poon RT, Ng KK. Comparison of percutaneous and surgical approaches forradiofrequency ablation of small and medium hepatocellular carcinoma. Arch. Surg. 2007; 142: 1136-1143.
20. Kariyama K, Nouso K, Wakuta A. Percutaneous radiofrequency ablation for treatment ofhepatocellular carcinoma in the caudate lobe. AJR Am. J. Roentgenol. 2011; 197: W571-575.
21. Peng ZW, Liang HH, Chen MS. Percutaneous radiofrequency ablation for the treatment ofhepatocellular carcinoma in the caudate lobe. Eur. J. Surg. Oncol. 2008; 34: 166-172.
22. Choi D, Lim HK, Rhim H. Percutaneous radiofrequency ablation for recurrent hepatocellularcarcinoma after hepatectomy: long-term results and prognostic factors. Ann. Surg. Oncol. 2007; 14: 2319-2329.
23. Poon RT, Fan ST, Lo CM. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann. Surg. 2001; 234: 63-70.
24. Verslype C, Van Cutsem E, Dicato M. The management of hepatocellular carcinoma. Currentexpert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann. Oncol. 2009; 20 (Suppl 7): vii1-vii6.
25. Zhu AX. Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: currentstatus and future perspectives. Semin. Oncol. 2012; 39: 493-502.
26. Makuuchi M, Sano K. The surgical approach to HCC: our progress and results in Japan. Liver Transpl. 2004; 10: S46-52.
27. Chen WT, Chau GY, Lui WY. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur. J. Surg. Oncol. 2004; 30: 414-420.
28. Chong CC, Lee K, Ip PC etal. Pre-operative predictors ofpost-hepatectomy recurrence of hepatocellular carcinoma: can we predict earlier? Surgeon 2012; 10: 260-266.
29. Allgaier HP, Deibert P, Zuber I, Olschewski M, Blum HE. Percutaneous radiofrequency interstitialthermal ablation of small hepatocellular carcinoma. Lancet 1999; 353: 1676-1677.
30. Lau WY, Leung T, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann. Surg. 2003; 237: 171-179.
31. Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M. Radiofrequency thermal ablation vs.percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis ofrandomized controlled trials. Am. J. Gastroenterol. 2009; 104: 514-524.
32. Lin SM, Lin C, Lin CC, Hsu CW, Chen YC. Randomized controlled trial comparing percutaneousradiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injectionto treat hepatocellular carcinoma of 3cm or less. Gut 2005; 54: 1151-1156.
33. Takaki H, Yamakado K, Uraki J etal. Radiofrequencyablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than5 cm. J. Vasc. Interv. Radiol. 2009; 20: 217-224.
34. Seror O, N'Kontchou G, Ibraheem M etal. Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes-initial experience in 26 patients. Radiology 2008; 248: 288-296.
35. Earl TM, Chapman WC. Conventional Surgical Treatment of Hepatocellular Carcinoma. Clin. Liver Dis. 2011; 15: 353-370, vii-x.
36. Wakai T, Shirai Y, Suda T etal. Long-term outcomes ofhepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4cm. World J. Gastroenterol. 2006; 12: 546-552.
37. Cho YK, Kim J, Kim WT, Chung JW. Hepatic resection versus radiofrequency ablation for very earlystage hepatocellular carcinoma: a Markov model analysis. Hepatology 2010; 51: 1284-1290.
38. Ruzzenente A, Guglielmi A, Sandri M. Surgical resection versus local ablation for HCC oncirrhosis: results from a propensity case-matched study. J. Gastrointest. Surg. 2012; 16: 301-311.
39. Kim YS, Lee W, Rhim H, Lim HK, Choi D, Lee JY. The minimal ablative margin of radiofrequencyablation of hepatocellular carcinoma (>2 and <5cm) needed to prevent local tumor progression: 3Dquantitative assessment using CT image fusion. AJR Am. J. Roentgenol. 2010; 195: 758-765.
40. Chen MS, Li JQ, Zheng Y. A prospective randomized trial comparing percutaneous local ablativetherapy and partial hepatectomy for small hepatocellular carcinoma. Ann. Surg. 2006; 243: 321-328.
41. Arii S, Yamaoka Y, Futagawa S etal. Results of surgicaland nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwidesurvey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: 1224-1229.
42. Tsoulfas G, Mekras A, Agorastou P, Kiskinis D. Surgical treatment for large hepatocellular carcinoma: does size matter? ANZ J. Surg. 2012; 82: 510-517.
43. Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S. Microsatellite distribution andindication for locoregional therapy in small hepatocellular carcinoma. Cancer 2005; 103: 299-306.
44. Kow AW, Kwon CH, Song S, Shin M, Kim JM, Joh JW. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution. Ann. Surg. Oncol. 2012; 19: 2246-2255.
45. Rossi S, Di Stasi M, Buscarini E. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am. J. Roentgenol. 1996; 167: 759-768.
46. Zagoria RJ. "Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer"-a commentary. AJR Am. J. Roentgenol. 2006; 187: 1149-1150.
47. Chan AC, Chan SC, Chok KS etal. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Liver Transpl. 2013; 19: 411-419.